Divisadero Street Capital Management, LP Harrow Health, Inc. Transaction History
Divisadero Street Capital Management, LP
- $742 Million
- Q3 2024
A detailed history of Divisadero Street Capital Management, LP transactions in Harrow Health, Inc. stock. As of the latest transaction made, Divisadero Street Capital Management, LP holds 36,108 shares of HROW stock, worth $1.27 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
36,108Holding current value
$1.27 Million% of portfolio
0.22%Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
177Shares Held
21.4MCall Options Held
845KPut Options Held
717K-
Opaleye Management Inc. Boston, MA3.99MShares$140 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$75.9 Million11.41% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$75.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$65.5 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$25.6 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $950M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...